Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Experimental Hematology & Oncology|April 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseStefanie Jilg, Richard T Hauch, Johanna Kauschinger, et al.
Blood Advances|December 7, 2018
Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesisCatharina Wenk, Anne-Kathrin Garz, Sonja Grath, et al.
Genes, Chromosomes & Cancer|April 18, 2019
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromesChristina Ganster, Catharina Müller-Thomas, Claudia Haferlach, et al.
Haematologica|May 14, 2016
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemiaPeter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, et al.
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Catharina Müller-Thomas, Katharina Götze, et al.
Cancer Letters|April 14, 2025
Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disordersCristiano Ramos, Natalie Walterskirchen, Viktoria Knöbl, et al.
Leukemia Research|April 30, 2013
Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic studyFriederike Braulke, Klaus Jung, Julie Schanz, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating AgentsSophie Park, Jean-François Hamel, Andrea Toma, et al.
Pageof 5